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This study was conducted to determine if 15 minutes of postprandial light walking has an effect 
on the glycemic response to a Boost® beverage in individuals with type 1 diabetes. Seven 
participants, 22.3 + 4.3 yrs, with type 1 diabetes completed the two days of data collection. On 
day 1, participants measured baseline fasting blood glucose (BG) with a glucometer, consumed a 
Boost® beverage, and sat quietly, repeating BG measurements 15, 30, 60, 90, and 120 minute. 
On day 2, participants repeated the protocol, but walked 15 minutes at a light pace (50-60% max 
HR) immediately after beverage consumption. The difference between peak and baseline BG 
was significantly lower on the walking day compared to the sedentary day (6.4 + 1.2 vs 4.0 + 
2.4, respectively, P < .05) as was the iAUC (468.6 + 94.5 mmol/L/120min vs 241.1 + 155.8 
mmol/L/120min, P < .05). In conclusion, light walking for 15 minutes postprandially can blunt 
the spike in BG and overall glycemic response to a breakfast beverage in young adults with type 
1 diabetes. 
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Introduction 
Statement of the Problem 
Type 1 diabetes manifests when there is no longer a production of insulin, which is a 
hormone secreted by the beta cells of the pancreas that normally acts to lower blood glucose 
(BG) levels, resulting in a hyperglycemic state. Another type of diabetes, type 2, occurs mainly 
in overweight and obese individuals; in this case, insulin is still produced by the pancreas, but is 
ineffective in maintaining normal BG. Only about 5-10% of the diabetic population are 
diagnosed with type 1 diabetes and live with it for majority of their lifetime, with some patients 
developing it at a very young age.1 In 2012, 29.1 million Americans had diabetes, with 1.25 
million of those with type 1 diabetes.2 Forty thousand people are diagnosed with type 1 diabetes 
every year and 5 million people are expected to develop type 1 diabetes by 2050, in the United 
States alone.3  
Type 1 diabetes is the more severe form of diabetes because the complete lack of insulin 
production by the pancreas can result in very high BG levels; no cure is available at this time. 
However, BG levels can be managed with insulin injections and a controlled carbohydrate 
intake. BG levels can become uncontrolled if insulin dosing and carbohydrate intake are not 
coordinated with each other, resulting in hypoglycemia or hyperglycemia.1 Currently, less than 
one-third of individuals with type 1 diabetes are considered to be in good glycemic control.3 
Hyperglycemia, if not treated promptly or left untreated for a long period of time, can result in 
complications including retinopathy, nephropathy, neuropathy, and cardiovascular disease 
(CVD), among others.1 
 Physical activity after a meal may be a tool in type 1 diabetes management to decrease 
postprandial BG and avoid hyperglycemia. Because exercising muscle does not require insulin 
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for glucose uptake, postprandial physical activity may blunt the spike in BG and overall 
glycemic response to carbohydrate, potentially resulting in better BG control over time, with the 
possibility of lessening the risk for the long term complications of diabetes and decreasing 
insulin dosages needed.4 Previous research has shown that 30 minutes of light walking after 
consumption of a candy bar blunted the glycemic response to a candy bar in healthy 
participants.5 Other studies with healthy participants and those at high risk for type 2 diabetes 
have shown similar effects of physical activity on the glycemic response to food.5-10  
Few studies have been conducted examining the effect of postprandial physical activity 
on the glycemic response in individuals with type 1 diabetes. Some of the studies were 
conducted between 1982 and 1994, before the insulin pump and intensive insulin therapy were 
commonly used. Intensive insulin therapy involves administering a bolus of fast acting insulin at 
each meal, in accordance with the carbohydrate content of the meal. This results in more precise 
glycemic control and greater meal flexibility than previous insulin regimens that involved 2-3 
insulin injections a day with a mixture of insulin types that peaked at specific times when meal 
with controlled carbohydrate content had to be consumed.  Studies have found a beneficial effect 
of postprandial physical activity on glycemic control was found in participants with type 1 
diabetes using varying insulin, meal, and physical activity regimens.11-13 In both of the 1982 
studies, participants were hospitalized and administered their usual insulin type and dosage, 
either intravenously or by artificial pancreas for 48 hours before the study, then commenced 
activity for 45 minutes on an exercise bike for 30 minutes after the beginning of breakfast.11,13  In 
1994, Rasmussen and coworkers  found favorable effects of 30 minutes of cycling that 
commenced 15 minutes after a meal was consumed in participants with provided insulin via an 
artificial pancreas for 2 hours before the meal followed by continuous insulin infusion for the 
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remainder of data collection.12 Years later, in 2002, the researchers found a similar beneficial 
effect of postprandial physical activity in patients using intensive insulin therapy; these 
participants were hospitalized for the study, but given long acting insulin the night before data 
collection, then given a bolus of regular insulin 30 minutes before meal consumption, which is 
not typical current protocol for intensive insulin therapy. In addition, the participants waited 30 
minutes after meal consumption to walk for 30 minutes.14  
To date, no studies have been conducted to determine the effect of postprandial physical 
activity on the glycemic effect of a meal in free-living participants using intensive insulin 
therapy or the pump following their usual insulin routine. In addition, a shorter bout of physical 
activity may be more realistic to implement in daily life. Even though postprandial physical 
activity has been found to be beneficial, there is also a potential risk of hypoglycemia or 
hyperglycemia in individuals with type 1 diabetes when participating in physical activity.15-17 
Thus, reducing the physical activity duration to 15 minutes would likely reduce the risk of 
hypoglycemia and be more realistic or convenient as part of the treatment regimen.   
Purpose of Study 
The purpose of this study is to determine if a 15 minute interval of light physical activity, 
consisting of walking immediately after consumption, would attenuate the glycemic response to 
a breakfast beverage in free-living individuals with type 1 diabetes following their usual insulin 
protocol.  
Research Questions 
1. Will 15 minutes of light physical activity immediately after consuming a breakfast beverage 
result in a lower spike in BG compared to being sedentary after consumption in individuals 
with type 1 diabetes? 
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2. Will 15 minutes of light physical activity immediately after consuming a breakfast beverage 
result in a smaller glycemic response, as determined by the incremental glucose area under 
the curve (iAUC), than being sedentary after consuming the beverage? 
 
Hypotheses 
1. Fifteen minutes of light physical activity immediately after consuming a breakfast beverage 
will result in a lower spike in BG compared to being sedentary in individuals with type 1 
diabetes. 
2. Fifteen minutes of light physical activity immediately after consuming a breakfast beverage 
will result in a smaller glycemic response indicated by the incremental glucose area under the 
curve (iAUC), compared to being sedentary after consumption. 
Significance of Study 
         This study will shed light on the potential benefit of timing of physical activity to 
enhance glycemic control in individuals with type 1 diabetes. Specifically, this study will 
examine the effect of postprandial physical activity on the glycemic response to a breakfast 
beverage as BG increases most dramatically after carbohydrate consumption. Better glycemic 
control will lead to better management of diabetes and potentially better overall health by 
possibility of decreasing the risk for secondary complications forming. Achieving better 
glycemic control with light postprandial walking would also lead to a decrease in the amount of 
insulin needed to achieve glycemic control and therefore lower the cost of supplies and 
medications. This study may promote further research to be conducted on this topic with 
participants with type 1 diabetes to confirm the duration and types of activity that have the most 
beneficial effects while minimizing hypoglycemia or hyperglycemia. In the end, postprandial 
physical activity could be included a part of routine diabetes management. 
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Literature Review 
Type 1 Diabetes: An Overview 
          Type 1 diabetes is the most severe form of diabetes and represents 5-10% of all diabetes 
diagnoses, occurring when there is no longer a production of the hormone insulin due to the 
destruction of the beta cells of the Islets of Langerhans in the pancreas. This can be caused by 
autoimmune destruction of beta islet cells or can be idiopathic, where the cause is unknown. A 
contributing factor can be genetic predisposition from a family history of type 1 diabetes along 
with a trigger by an environmental exposure. Insulin is required for the uptake of glucose by the 
GLUT 4 transporter in muscle and adipose cells. Insulin’s normal function is to facilitate glucose 
entry into cells where it is involved in metabolic pathways, such as glycolysis, and ultimately 
provides substrate for the production of ATP via aerobic metabolism. Insulin also lowers BG by 
stimulating the storage of glucose as glycogen in the liver and muscle, and inhibiting glycogen 
breakdown (glycogenolysis). In addition to glucose metabolism, insulin influences fat 
metabolism by promoting fat storage and inhibiting fat breakdown, and promotes amino acid 
entry into cells, enhancing muscle protein synthesis. Thus, insulin, which promotes glycogen 
formation and fat and protein synthesis is considered an anabolic hormone. When insulin is 
absent, as in type 1 diabetes, glucose levels in the blood rise because glucose does not enter 
muscle and adipose cells. In addition, anabolic processes are not inhibited, resulting in a 
catabolic state where the release of glucose from the liver glycogen stores, and gluconeogenesis 
from the conversion of some amino acids from catabolized protein and the glycerol portion of 
catabolized triglycerides further contribute to hyperglycemia.1 GLUT 4 transporters, however, 
are not dependent on insulin for the uptake of glucose while skeletal muscle is contracting during 
physical activity.4 
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     The symptoms that present with type 1 diabetes, in addition to hyperglycemia, are 
polyuria, polydipsia, polyphagia, dehydration, electrolyte disturbance, fatigue, blurry vision, 
slow healing process, weight loss, and sometimes ketoacidosis.1 Diabetic ketoacidosis (DKA) is 
a life-threatening condition that presents with symptoms of dyspnea, abdominal pain, and 
vomiting.18 The lab values that determine a type 1 diabetes diagnosis include a fasting plasma 
glucose of 126 mg/dL on two separate occasions, a casual, non-fasting BG of 200 mg/dL with 
symptoms present, or a glycated hemoglobin (HbA1c) value 6.5% or greater. A simple oral 
glucose tolerance test (OGTT) can also be used to diagnose type 1 diabetes. The procedure 
includes an 8 hour fast previous to the ingestion of a glucose solution that is 1.75 g of glucose 
per kg of ideal body weight, with the maximum dosage of 75 g. The patient will then have their 
BG tested two hours after ingestion. There is another version of the OGTT that requires a 12 
hour fasting period prior to the test and more frequent BG readings taken: fasting then at 30-60 
minute intervals for two to five hours. Diabetes is diagnosed in both tests when the BG reading is 
greater than 200 mg/dL 2 hours after solution ingestion.1 
Management of Type 1 Diabetes 
         There is currently no cure for type 1 diabetes, but this condition can be managed by 
controlling BG levels using an insulin regimen, diet, and physical activity under the guidance of 
an endocrinologist and a certified diabetes educator (CDE), along with other medical 
professionals. Medical nutrition therapy goals, established by the American Diabetes 
Association, include maintaining certain lab values, such as BG levels within a normal range 
established for individuals with diabetes, a normal blood lipid profile, and normal blood pressure 
level.19 Achievement of these goals will help prevent or delay the development of the long-term 
complications of diabetes. A CDE would teach individuals with diabetes how to achieve these 
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goals with insulin and a diet that meets the individual’s nutritional needs, while keeping food 
items that they enjoy. The goals to indicate glycemic control include:  
● HbA1c less than 7% and less than 7.5% in children and adolescents;  
● pre-meal BG of 80-130 mg/d; 
● peak postprandial BG less than 180 mg/d; 
●  LDL cholesterol less than 100 mg/dL; 
●  HDL greater than 40 mg/dL and 50 mg/dL in men and women respectively; 
● triglycerides less than 150 mg/dL; 
● blood pressure less than 130 over 90 mmHg1,20-21    
         Insulin dosages and type of insulin medications used are dependent on the individual’s 
lifestyle with factors such as meal times and daily activity level taken into consideration. There 
are short acting, rapid acting, intermediate acting, long acting, and mixtures of insulin that can be 
used in insulin regimens. The type and the number of insulin medications used also depends on if 
the patient is using two to three insulin injections a day coordinated with meal times, which is the 
conventional regimen, or using the intensive regimen, including multiple daily injections or an 
insulin pump. With multiple daily injections, individuals with diabetes would use a long acting 
once a day and rapid acting insulin at meals and for BG corrections. If the individual were using 
an insulin pump, then rapid acting insulin would be administered in small doses, automatically, 
throughout the day to mimic the baseline output of insulin that a healthy pancreas would 
produce, and additional doses, manually, at meals and for corrections of high BG levels. For an 
individual with type 1 diabetes, the required insulin dosage is 0.5 to 1 unit/kg of body weight, 
with 50% of the total daily insulin dose contributing to the basal insulin.1  
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In terms of diet, individuals with type 1 diabetes are mainly advised to be conscious of 
their carbohydrate consumption and to do so by using one of two methods. One method is the 
carbohydrate counting method where each carbohydrate “exchange” is a type and amount of 
food that contains 15 grams (g) of carbohydrates. Individuals using the carbohydrate counting 
method know how many units of insulin are needed for a certain amount of carbohydrates (their 
insulin to carbohydrate ratio). A more extensive exchange method can be used to control calorie, 
protein, carbohydrate, and fat intake. The individuals using this method would be prescribed a 
diet with a defined number of exchanges from the starch, fruit, vegetable, milk, meat, and fat 
exchange groups at each meal or snack. Then a bolus of insulin would be injected in an amount 
appropriate for the carbohydrate load consumed at each meal or snack, according to their insulin 
to carbohydrate ratio. If the individual is on a conventional regimen, 2-3 injections of mixtures of 
insulin types that peak at different times of the day are administered. They are instructed on the 
number of carbohydrate exchanges they are allowed at each meal and snack, and aware of the 
times they must consume carbohydrate; carbohydrate consumption is timed to coordinate with 
insulin peaks and, therefore, timing is important.1 Individuals with type 1 diabetes also need to 
be aware of their fat consumption because of the complications, such as CVD and stroke, that are 
affected by fat intake. They would be advised to consume more omega-3 fatty acids and limit the 
consumption of saturated fats, trans fats, and cholesterol to decrease inflammation and their risk 
of secondary complications.22,23 
Diabetes Complications 
If glycemic control is poor, complications can develop. Hypoglycemia can occur if too 
much insulin administered or if an inadequate amount of carbohydrates are consumed for the 
insulin to carbohydrate ratio given. Hypoglycemia can also occur during or after physical activity 
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because exercising muscle can take up BG without insulin, which means that individuals with 
type 1 diabetes will need to monitor their BG often to ensure that glycemic control is maintained. 
Hypoglycemia can be treated with the consumption of a 15 g carbohydrate glucose tablet or 
snack. If the BG becomes so low that the individual passes out, then an emergency glucagon shot 
should be administered by someone. Hyperglycemia is a hallmark of type 1 diabetes diagnosis, 
but it can also develop if insulin dosages are not adequate to cover a carbohydrate load, leading 
inadequate BG uptake by cells and catabolism of muscle and fat. Diabetic Ketoacidosis (DKA) 
can develop from hyperglycemia when there is inadequate glucose in the cell to facilitate normal 
carbohydrate and fat metabolism, resulting in energy production that mimics starvation. In this 
case, fatty acids are broken down into two carbon molecules called Acetyl CoA, which are then 
converted to ketones rather than entering the Krebs cycle for aerobic metabolism. Ketones are 
acidic and, with prolonged hyperglycemia, the concentration of ketones becomes so high that 
DKA occurs and the body goes into a toxic, acidic state. Muscle protein and fat breakdown will 
also occur because the anabolic effect of insulin on fat and muscle protein synthesis is lost, and 
the body goes into a catabolic state. When muscle protein is catabolized, some of the amino acids 
can and glycerol from catabolized fat can be converted to glucose as described earlier, further 
elevating BG levels. When high BG levels are extreme, frequent, and not properly corrected in 
individuals with type 1 diabetes, the risk of complications increase significantly.1  
Long term complications of type 1 diabetes include microvascular and macrovascular 
complications. Microvascular disease complications occur more frequently in individuals with 
type 1 diabetes than macrovascular complications, which include coronary heart disease, 
peripheral vascular disease, cerebrovascular disease, dyslipidemia, and hypertension. However, 
individuals with type 1 diabetes are still at risk for developing macrovascular diseases.1  
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Microvascular diseases include nephropathy, retinopathy, and neuropathy. These 
conditions develop from experiencing hyperglycemia for a long period of time; excess glucose in 
the small blood vessels in the kidney, eye, and nerves will attach to and impair proteins in those 
areas. When proteins in artery walls, like collagen, are damaged by excess glucose, plaques will 
build up in small and large blood vessels, decreasing blood flow to the tissues they supply, 
resulting in tissue damage. In cells that do not require insulin for glucose uptake, the levels of 
glucose inside the cells becomes too high, and glucose enters the cell following the concentration 
gradient, which also damages cells and impairs their function. The early evidence of nephropathy 
is microalbuminuria, which is considered to be a value greater than 30 mg/dL; a slow 
progression into end stage renal disease usually ensues. Retinopathy occurs when there is a loss 
of retinal vasculature and ischemia with increased occurrence of hemorrhages, leading to 
increased ocular pressure and glaucoma formation. The lens of the eye will swell from 
hyperglycemia and cause a temporary blurred vision. Neuropathy occurs in 60-70% of 
individuals with diabetes and is characterized by peripheral nerve damage to feet and hands as 
well as autonomic nerve damage resulting in impairment in the impulses to the heart, and can 
cause impotence and gastroparesis.1 Gastroparesis is characterized by delayed gastric emptying 
caused by the damage of the vagus nerve, which normally allows for the proper movement of 
food through the digestive tract. This condition will make managing BG levels more difficult 
since food is not able to pass through the digestive tract normally, altering absorption rate from 
typical rates. When the food finally enters the small intestine, then the BG will elevate, but the 
timing of the BG response to carbohydrate will be altered.24 Gangrene can also develop from 
neuropathy when there is a lack of nerve sensation to the feet resulting in an injury that goes 
untreated. The poor circulation due to macrovascular complications, including peripheral 
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vascular disease, limits the delivery of substances needed for proper wound healing. The 
combination of a wound, poor circulation, and hyperglycemia lead to infection, which sometimes 
leads to gangrene and the need for amputation.1  
Some of the other complications of diabetes include cognitive impairment and 
macrovascular complications such as atherosclerosis, which increases the risk for heart attack, 
stroke, and peripheral vascular disease. Hyperglycemia can also increase the formation of 
advanced glycation end products (AGEs) in the body, which are produced by the post-
translational modification of proteins, lipids, or DNA.25,26 AGEs will normally form at a slow, 
constant rate, from early embryonic development throughout adulthood, accumulating over time. 
However, AGE formation is accelerated in diabetes due to constant elevated BG levels.27,28 
AGEs result in the crosslinking of collagen and stiffening of connective tissue, including tissue 
in the arteries. This will cause irreversible damage to tissues and therefore activate macrophages, 
monocytes, cardiac fibroblasts, and vascular smooth muscle cells. Not only will hyperglycemia 
affect the development of atherosclerosis, but it will also increase the risk of the production of 
reactive oxygen species (ROS) that will then promote the oxidation of DNA and membrane lipid 
peroxidation.25 Therefore, elevated BG levels stimulate inflammation by promoting the 
production of free radicals and other pro-inflammatory chemicals. Chronic inflammation is 
related to the progression of CVD, cancer, and Alzheimer's disease.5,29,30 Peppa et al, suggest that 
AGEs are important pathogenic mediators of almost all of the complications that can form 
secondary to diabetes, on both macro- and micro- levels.27 
Glycemic Index and Response 
The glycemic response to food consumption refers to the extent and duration of the 
increase in BG after eating. The glycemic index (GI) is a dietary tool used to measure the effect a 
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food has on an individual’s BG concentration in comparison to a standard food, such as white 
bread. The GI is represented as number that reflects the area under the glucose curve (AUC) after 
consumption of a 50 g load of carbohydrate. Foods that are high in refined and simple 
carbohydrates that tend to have a high GI, are absorbed quickly and result in BG spikes of 
greater magnitude than carbohydrate containing foods that have fiber. The processes that 
influence the changes in BG concentration include the speed of carbohydrate hydrolysis and 
absorption in the small intestine, insulin secretion, and the tissue uptake of glucose in response to 
insulin.31 It is important to note that the GI of a food is based on a portion that would provide 50 
g of carbohydrate, some foods that have a high GI do not affect the BG to the magnitude 
expected from the GI because a 50 g portion is not typically consumed. For example, carrots 
have a high GI, but a typical portion provides approximately 5 g of carbohydrate. So some prefer 
to use the “glycemic load” (GL), which is calculated using the GI of the food multiplied by the 
amount of carbohydrate per serving. So although the GI of carrots is high, the GL is much lower. 
In any event, the GI is not normally used in type 1 diabetes management, but it is used to explain 
the glycemic response to certain food types. In one study of participants with type 1 diabetes 
who participated in physical activity, the use of the GI was effective towards the prevention of 
hypoglycemia. When a high GI meal was consumed after 45 minutes of physical activity at 70% 
VO2 max in participants with type 1 diabetes, the glycemic response to the meal was similar to 
the response in the participants that consumed a low GI meal.32 The GI can potentially have 
beneficial effects in other aspects of diabetes in addition to BG response. Pereira et al, examined 
the effect of a low GI diet on satiety, insulin resistance, serum triglycerides, C-reactive protein, 
and blood pressure in comparison to a low fat diet. They found that a low GI diet increased 
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satiety, and decreased insulin resistance, serum triglycerides, C-reactive protein, and blood 
pressure.33 
However, foods are not always consumed in isolation and the glycemic response will be 
reflective of the combination of foods consumed. For example, in one study, three different diets 
with different combinations of high or low GI foods and varying carbohydrate and calorie 
contents were consumed by non-diabetic obese and overweight participants. Results indicated 
that the combination of low GI and low calorie foods with a moderate amount of carbohydrate 
would be more effective at decreasing body weight and controlling BG levels than consuming a 
diet with high GI foods.34  
Physical Activity and Glycemic Control 
As mentioned previously, working, or exercising muscle, does not require insulin for 
glucose entry; therefore, physical activity influences BG levels, with the magnitude of effect 
depending on the duration and the intensity of the physical activity. Glucose enters muscle cells 
by facilitated diffusion via the GLUT4 transport proteins that reside inside muscle cells; glucose 
can also enter adipose cells through the GLUT4 transporter. GLUT4 receptors cannot facilitate 
glucose uptake unless they translocate to the surface of the cell. Insulin is the signal for this 
translocation, but muscle contractions can facilitate this translocation independent of insulin. 
Once inside the cell, glucose is then converted into energy, via glycolysis, Kreb’s Cycle, and the 
electron transport chain, to help the body maintain energy levels during physical activity. Insulin 
plus muscle contraction has a synergistic effect that promotes glucose uptake by muscle cells and 
thus may be particularly effective in mitigating BG spike after carbohydrate consumption in 
individuals with type 1 diabetes who are using intensive insulin therapy, which includes 
administering rapid acting insulin with meals. There is also an increased expression of GLUT 4 
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receptors on the cell surface of the skeletal muscle with physical activity, which improves insulin 
action, glucose uptake, and glycogen storage in both healthy individuals and individuals with 
type 1 diabetes. Another reason for increased BG uptake during physical activity is the fact that 
blood flow is increased during physical activity; BG uptake is directly correlated to blow flow. 
During physical activity, the blood flow can be increased up to 20 fold compared to at rest. 
When physical activity is prolonged, the liver is depleted of glycogen and cannot compensate for 
the glucose being taken in by the skeletal muscle. Therefore, hypoglycemia can occur, especially 
in individuals with type 1 diabetes. This can be prevented if an individual consumes some form 
of carbohydrate before the physical activity to provide the arterial blood with glucose so that 
homeostasis can occur.4,35 Exercise physiology is slightly different in individuals with type 1 
diabetes than healthy individuals. Because the pancreas does not respond to BG fluctuations, 
imbalances can occur with the additional hormonal responses involved with physical activity and 
BG control, such as glucagon, catecholamines, and glucocorticoids. As a result, hypo- or 
hyperglycemia can occur in individuals with type 1 diabetes in response to physical activity. 
With moderate aerobic physical activity, the pancreas does not respond to a decrease in BG by 
limiting insulin secretion, which, in the case of type 1 diabetes, the insulin in the system is from 
an injection. This can lead to a decrease in BG. With intense anaerobic physical activity, the 
pancreas of the individual with type 1 diabetes cannot alter insulin secretion to counteract the 
hormones that increase BG during physical activity, and hyperglycemia could result.36 
Hyperglycemia caused by physical activity may be due to low insulin concentrations and the 
body releasing counter-regulatory hormones including glucagon and epinephrine which stimulate 
glycogenolysis glycogen in response to increased energy needs; regulating insulin levels during 
physical activity  with a continuous blood glucose monitoring device could prevent this.12 
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As mentioned in the section on the overview of type 1 diabetes, some level of physical 
activity is a part of the management plan to achieve glycemic control. The American Diabetes 
Association has included in the 2015 Standards of Medical Care in Diabetes that the time that 
individuals with diabetes spend sedentary should be broken up by some form of physical activity 
in order to promote BG control; they suggested less than every 90 minutes.21 To support that, in a 
study with individuals with type 2 diabetes, researchers found that breaking up prolonged 
sedentary activity with 5 minute, light intensity intervals of standing or walking, for every 30 
minutes of sitting, decreased the postprandial BG levels in postmenopausal women.6 The 
National Institutes of Health (NIH) wrote an article on recommendations of exercise as part of 
the diabetes management plan. Thirty to sixty minutes of moderate to vigorous physical activity 
most days of the week is recommended; however, it is important for individuals with type 1 
diabetes to avoid vigorous physical activity when ketones are present in the blood or urine since 
hyperglycemia could result.37  The Joslin Diabetes Center advises individuals with diabetes to 
avoid exercising when BG levels are above 250 mg/dL and ketones are present. If there are no 
ketones present, the individual with a BG of 300 mg/dL or higher can participate in physical 
activity if their BG decreases within 5 to 10 minutes. If there is no decrease, they should refrain 
from exercising.38  
The effect of postprandial physical activity on the glycemic response to food has been 
investigated in healthy individuals mostly, and may potentially help with glycemic control in 
individuals with type 1 diabetes. In one study, the effect of postprandial walking at a light pace 
for 30 minutes, compared to being sedentary, on the glycemic response to a Milky Way® candy 
bar in healthy individuals was determined. The investigators found that postprandial walking 
reduced the BG spike at 30 and 60 minutes after consumption of a high sugar candy bar.5 There 
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was a different approach to intervention of physical activity in another study with elderly 
participants at risk for glucose intolerance. In this study, there were two types of interventions: 
three 15-minute intervals of postprandial physical activity bouts vs 45 minutes of sustained 
walking. The study revealed that the 15-minute interval sessions of walking had a greater effect 
on lowering BG concentration and, therefore, was the better method of physical activity for 
glycemic control.7 An extensive review was also conducted to describe evidence on strategies to 
minimize the glycemic effect of food consumption in obese adults at risk or have diabetes. The 
authors concluded that postprandial activity could be a solution of mitigating the BG spike rather 
than consuming a low glycemic diet, which was found to be undesirable, unrealistic, and 
difficult. If postprandial physical activity does prove to be effective at blunting the BG spike 
postprandially, it could be a low cost and convenient method to prevent the damaging 
consequences of elevated BG.8 Other research has shown that cycling (30-minute 70% maximum 
heart rate) blunts the BG spike after consumption of corn flakes (1 g of carbohydrate per kg body 
weight). The physical activity lowered the BG levels with a similar to the effect of hypoglycemic 
drugs.9 Another study examined  the effect of postprandial physical activity on BG in women 
over 50 years old. The participants were sedentary, walked 15 minutes, or 40 minutes after 
consuming the same meal described in the previous study. The results again showed that 
postprandial walking after a high carbohydrate meal can decrease the BG spike and the 
incremental area under the glucose curve (iAUC).10 The appropriate time allowance of physical 
activity and intensity still needs to be determined, but from the studies published to date, it seems 
that between 15-30 minutes of physical activity has the most beneficial effect on glycemic 
control compared to a longer interval of physical activity. 
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When comparing physical activity’s effect on BG concentration in individuals with type 
1 diabetes to healthy individuals, there are several factors to consider. Individuals with type 1 
diabetes will not have the insulin production that healthy individuals do after food consumption, 
and therefore certain metabolic processes will be influenced by the presence or lack of insulin. 
However, as long as individuals with type 1 diabetes follow their insulin regimen and monitor 
BG levels often, the glucose concentrations should be near normal. The earliest studies found 
examined the effect of postprandial physical activity on BG response in participants with type 1 
diabetes were published in 1982, 1994, and 2002, before intensive insulin therapy became 
common.  In 1982, Nelson et al examined the BG response to 45 minutes of moderate 
postprandial physical activity (55% VO2 max), on a bicycle ergometer, in participants with and 
without type 1 diabetes. The participants with diabetes used an artificial pancreas during the 
study, which involves increases or decreases of insulin infusion based on BG level, and 
consumed a breakfast with an estimated carbohydrate total of 48.4 g. The physical activity 
commenced 30 minutes after breakfast. In both participants with and without type 1 diabetes, the 
physical activity resulted in BG levels returning to the fasting level at a rapid rate. The physical 
activity resulted in a decrease in the amount of insulin needed for glycemic control compared to 
the amount infused without exercising after eating, providing evidence that postprandial physical 
activity may indeed reduce insulin dosages needed for glycemic control.11 Another study 
published in 1982 examined the effect of postprandial physical activity on the glycemic response 
to breakfast and lunch. The participants were sedentary one day after meal consumption and, 
another day, performed 45 minutes of moderate physical activity 30 minutes after breakfast on 
another day. Insulin infusion was used the night before the study days to that fasting BG were 
similar on both days, then participants administered their usual insulin regimens. Breakfast and 
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lunch were provided on both days, containing 52.5 and 53.6 g of carbohydrates, respectively. 
They found an improved glycemic control in response to both breakfast and lunch meals with 
postprandial physical activity.13 In 1994, Rasmussen and coworkers examined the effect of 30 
minutes of cycling at 65% VO2 max commencing 15 minutes after a breakfast composed of 50 g 
of carbohydrate from white bread. An artificial pancreas was used to achieve normal BG on the 
test days, then insulin was continuously infused for the remainder of the test periods.  The results 
showed that although the peak BG were similar on both days, the glycemic response (AUC) was 
decreased by one third.12 Years later, in 2002, the researchers found a similar beneficial effect of 
postprandial physical activity in patients using intensive insulin therapy, but these patients were 
hospitalized for the study, given long acting insulin the night before data collection, then given a 
bolus of regular insulin 30 minutes before meal consumption, which is not typical current 
protocol for intensive insulin therapy. In addition, the participants waited 30 minutes after meal 
consumption to walk for 30 minutes.14 
Other, more recent studies have also found a beneficial effect of postprandial physical 
activity on glycemic control in those with type 1 diabetes. Manohar et al, compared the glycemic 
response to a meal with and without 30 minutes of postprandial physical activity in both healthy 
participants and participants with type 1 diabetes. The results indicated that walking was 
beneficial for the postprandial blood glycemic control in both those with and without diabetes, 
but the attenuation of BG with postprandial physical activity was much greater in individuals 
with diabetes. In this study, the participants with type 1 diabetes were using an artificial 
pancreas.39 In another study, the association of physical activity (not specifically postprandial) 
and glycemic control were examined in participants were individuals with type 1 diabetes and 
their non-diabetic siblings between the ages of 8 and 16. Results indicated that moderate to 
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vigorous physical activity can result in better glycemic control for individuals with diabetes.15 To 
support that conclusion, the study by Campbell, et al. found men with type 1 diabetes who 
participated in physical activity 45 minutes after consuming a high GI meal, on the day of data 
collection, experienced a response to postprandial BG concentrations similar to the participants 
that consumed a low GI diet, meaning that vigorous physical activity can promote better 
glycemic control.32  
Factors Influencing Physical Activity in Individuals with Diabetes 
Health care professionals advise individuals with type 1 diabetes that regular physical 
activity should be a part of their lifestyle; however, not every patient follows that 
recommendation. Research has examined the lifestyle habits, including physical activity, of 
children, adolescents, and young adults with type 1 diabetes. A survey was conducted to gather 
information on lifestyle habits, such as media consumption and physical activity, and their 
association with HbA1c. The average weekly time spent exercising among the participants was 
5.1 + 4.5 hours.  The results showed that there was not a significant effect of physical activity 
level on HbA1c, with the HbA1c ranging from 8.6-8.9%. However, the amount of time spent on 
daily media, how long they had diabetes, and socioeconomic status were related to poorer 
glycemic control. Even though the data did not find a direct relationship between physical 
activity and glycemic control, indirectly, media consumption likely resulted in a more sedentary 
lifestyle, which did affect HbA1c and, therefore, glycemic control.40 Level of motivation for 
physical activity can influence the amount of physical activity accomplished. One research group 
believes that the reason for the lack of physical activity in patients with diabetes, both type 1 and 
2, is the absence of initiative or intention to work out as explained by the social cognitive theory 
of planned behavior. The social cognitive theory of planned behavior contends that social 
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influence and its emphasis on external and internal social reinforcement has an affect on 
behavior outcomes.41 Other researchers contend fear of hypo- or hyperglycemia occurring during 
and after physical activity is another reason deterring individuals with type 1 diabetes from 
participating in physical activity.12,15-17 Many factors influence the BG response to physical 
activity including environment, stress and nutritional status, regimen changes, and physiology. 
The researchers proposed that an “exercise calculator” device should be developed that would 
calculate the insulin correction needed for physical activity, either an increase or decrease in 
insulin, that would prevent prolonged hypoglycemia or hyperglycemia.16 However, monitoring 
BG frequently before, during, and after physical activity will have similar effects on avoiding 
hypo- or hyper-glycemia. BG levels also depend on the when physical activity is performed in 
relation to the meal consumption. A review article stated that pre-meal physical activity can 
cause the BG levels to increase immediately following a bout of physical activity and that there 
was only a slight risk of hypoglycemia, which depended on the level of physical activity in 
individuals with type 2 diabetes, metabolic syndrome, type 1 diabetes, and insulin resistance. 
Physical activity performed 30 to 45 minutes postprandial decreased BG in individuals with type 
2 diabetes, metabolic syndrome, type 1 diabetes, and healthy individuals. High intensity physical 
activity at this time did not result in the BG increasing as it did with pre-meal physical activity. 
However, in the late postprandial period, there was a elevation in BG, but in healthy 
individuals.42 
Glycemic Control and the Development of Diabetes’ Complications 
Better glycemic control can be accomplished through proper diet, insulin regimen, and 
physical activity; with better glycemic control, there can be a decreased risk of developing 
diabetic complications. As mentioned in an earlier section on diabetes complications, neuropathy 
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is one of the microvascular complications that can occur with uncontrolled diabetes. The level of 
physical activity can influence the course of diabetic neuropathy in individuals with type 1 
diabetes. In one study, the development of small and large fiber neuropathy in individuals with 
type 1 diabetes was evaluated to determine if elevated HbA1c and AGEs were contributing 
factors. The participants were followed for 27 years and the nerve function was evaluated by 
nerve condition studies at years 8, 17, and 27. The majority of the participants (81%) were 
diagnosed with small nerve neuropathy with the remaining of the participants developing large 
nerve neuropathy. It was found that small nerve fibers might be more sensitive to changes in BG 
levels; thus, glycemic control is important in order to prevent small nerve damage.43   
Two of the other microvascular diabetes complications, retinopathy and nephropathy, 
were also examined. A study focused on the relationship between retinopathy and nephropathy 
development in those with type 1 diabetes for six and a half years. The conclusion was that the 
incidence of the progression of retinopathy was more rapid in participants that had nephropathy 
compared to participants that did not have nephropathy and vice versa. Therefore, the presence 
of the microvascular complications increased the risk of each other.44 Waden et al, examined the 
effect of physical activity on the development of nephropathy. A self-evaluation questionnaire 
was given to determine the level of physical activity for each participant. Even though there was 
no association found between the progression of renal status and physical activity, the authors 
concluded that physical activity intensity might have an effect on the initiation and progression 
of nephropathy.45 With persistent hyperglycemia, HbA1c levels will be higher more AGE’s will 
form, contributing to more proteins in the small blood vessels and nerves becoming glycosylated. 
Postprandial physical activity may help reduce the chances of protein dysfunction, and therefore 
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decrease the risk of diabetic microvascular complications and other adverse effects such as 
amputation, blindness, and or kidney failure.18,24 
CVD risk is increased in individuals with type 1 diabetes due to several factors, including 
other complications that come with type 1 diabetes. Hyperglycemia can promote oxidative stress 
in the body by causing inflammation and therefore promote atherosclerosis formation.24,46 
Constant states of hyperglycemia can also cause the arteriole walls to become brittle due to 
glycosylation or calcification of the arteries. Neuropathy is another factor that increases the risk 
of CVD in individuals with type 1 diabetes. The impaired function of the nerves can impair the 
myocardial function and restrict the blood flow to the heart, promoting CVD. Individuals who 
have type 1 diabetes and follow an unhealthy diet will also have an increased risk for CVD. 
When individuals with type 1 diabetes do not inject adequate insulin, BG levels will be elevated 
and additional insulin will be needed to correct the BG and reach homeostasis. If the 
carbohydrate intake is over the threshold for energy production, then the remaining glucose will 
be converted into fat and stored. If this becomes a habitual diet, the increased fat storage will 
result in an increase in LDL levels, and an increased risk of hypertension, atherosclerosis and 
CVD, and stroke.24 Continued excessive fat storage will then contribute to weight gain, leading 
to a body mass index (BMI) of overweight or obese status, which increases the risk of CVD.47 
The inflammation caused by hyperglycemia can also contribute to the development of CVD. In a 
population based cohort study with individuals with type 1 diabetes, Grauslund et al examined 
the relationship between glycemic control and the presence of dyslipidemia and renal 
dysfunction, as well as all cause and CVD mortality, and ischemic heart disease. The participants 
had lived with type 1 diabetes for at least 20 years and were followed for a 13-year time period, 
ample time for complications and or mortality to occur. The study found that, with long-term 
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glycemic and metabolic control, the individuals with type 1 diabetes had less macrovascular 
damage. Therefore, glycemic control, dyslipidemia, and renal dysfunction were all related to the 
all cause mortality outcome and ischemic heart disease development in the study participants.48 
Some individuals with type 1 diabetes and atherosclerosis need coronary bypass surgery. 
Therefore, postoperative issues need to be considered as complications from type 1 diabetes. In a 
study done in Sweden, the researchers observed type 1 diabetic patients’ HbA1c levels and the 
mortality or adverse cardiovascular effects present. The researchers determined that if the bypass 
patients had poor glycemic control before surgery, then they had a higher risk of mortality and 
adverse cardiovascular outcomes.49 Therefore, not only would postprandial physical activity 
have a beneficial effect on glycemic control, may reduce postoperative complications and 
mortality risk. 
         Obesity does not only occur in type 2 diabetes; the epidemiological shifts in the 
population and increased calorie intake in individuals have contributed to an increase in the 
percentage of individuals with type 1 diabetes who are obese; the prevalence of obesity has 
increased from 1% to 31%, in individuals with type 1 diabetes, as reported in the 1993 Diabetes 
Control and Complications Trial (DCCT).50,51 Clinical trials have provided evidence that 
intensive insulin therapy can result in excessive weight gain in a subset of patients with type 1 
diabetes. Obesity in individuals with type 1 diabetes is directly related to increased risk for CVD 
by increasing CVD risk factors such as increased visceral adiposity, high blood pressure, 
increased levels of LDL lipoproteins, and insulin resistance. Insulin resistance is also known to 
increase the risk in coronary heart disease in individuals with type 1 diabetes as well.50 To 
further support this point, Brazeau et al, indicated in their literature review that individuals with 
type 1 diabetes are known to decrease their physical activity because of the risk of 
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hypoglycemia. However, without physical activity present in the lifestyle, individuals with type 
1 diabetes can be at risk for weight gain, which can then lead to obesity. This study found that 
increased physical activity in type 1 diabetics resulted in a decrease in BMI and body fat 
percentage, although that there was no change in the HbA1c and insulin dosages.52 
A stroke, another complication of type 1 diabetes, occurs when there is a blood vessel 
blockage in the brain, cutting of blood flow, and thus oxygen and nutrient delivery to the brain 
tissue, which results in tissue death. The blockage occurs when a blood clot gets stuck in an 
artery narrowed by atherosclerosis. Individuals with type 1 diabetes are at risk for experiencing a 
stroke at some point in their lives because of the macrovascular damage that is caused by high 
glucose concentrations, elevated fat and cholesterol intake, and weight status. AGEs can 
contribute to the potential increased severity of a stroke associated with diabetes by contributing 
to the neurotoxicity.53 In one study, other diabetes complications, retinopathy and neuropathy, 
were examined in relation to stroke incidence. The researchers did find a positive correlation 
between the presence retinopathy and neuropathy, independently, and the risk of stroke occurring 
in individuals with type 1 diabetes.24,54 
Expenses of Type 1 Diabetes 
Besides preventing the development of the complications of type 1 diabetes, glycemic 
control promoted by postprandial physical activity could have a significant effect on the cost of 
diabetes management. Diabetes comes with many expenses including supplies for insulin 
injections and BG monitoring, multiple physicians appointments for management and check-ups 
on complications, and additional medication to manage and treat the complications of diabetes. 
A 2010 study on the cost of managing type 1 diabetes using a national dataset the estimated cost 
per year was $10.6 billion, during the years 1999 and 2005, and $422.9 billion for a lifetime, 
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which included both self-payments and third party insurance payments. The expenses included 
hospital inpatient stays, ambulatory visits, emergency room visits, prescription drugs, medical 
supplies, home health providers, and vision and dental screening and treatments. These estimates 
represent the costs of both type 1 and type 2 diabetes combined. The researchers calculated that 
the overall direct medical cost per capita was $9,868 per patient year, with $6,288 attributed to 
type 1 diabetes.55 The Juvenile Diabetes Research Foundation (JDRF) recently reported that 
annual healthcare costs associated with type 1 diabetes in the United States is estimated to be $14 
billion.3 Between December 2008 and December 2010, researchers reported the cost of 
medication for diabetes medication and management, medical tests, and consultations with 
physicians and dietitians for individuals with type 1 diabetes in Brazil. The expenditure on 
outpatient treatment alone was $1,216.33 per patient per year, with the average annual cost being 
$3,867,915.66, which represents about 92% of the overall direct medical cost. The outpatient 
treatments included insulin, oral drugs, supplies to monitor BG, insulin pump and supplies, and 
medical procedures, including hemodialysis. Insulin was estimated to be $348.78, oral drugs 
$27.60, supplies for BG monitoring $696.78, insulin pumps and supplies $72.53, and medical 
procedures $75.64, all representing per capita per year. The United States is known to have 
extremely high medical costs compared to some other countries, and therefore the costs would 
reflect a different amount than Brazil, and taking the inflation over the years into consideration.56 
According to Accu-Chek®, the average cost of an insulin pump is $6,500 in the United States, 
with an additional average expense of $1,500 per year for the pump supplies.57 However, the cost 
of type 1 diabetes can be much greater depending on the amount and type of supplies, number of 
visits to physicians and other health professionals, and the amount that medical insurance covers.   
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Summary 
From this literature review on type 1 diabetes, glycemic control, and physical activity, 
there appears to be evidence that postprandial physical activity may blunt the glycemic response 
to a meal containing carbohydrates in individuals with type 1 diabetes. This study can add to the 
evidence by determining if a short bout, 15 minutes, of low intensity physical activity after 
consumption of a carbohydrate-containing breakfast beverage specifically can attenuate the spike 
in BG and the overall glycemic response specifically with participants with type 1 diabetes in a 
free-living situation. To date, several similar studies have been conducted that show promising 
effects of postprandial physical activity on the glycemic effect of a carbohydrate load, but no 
controlled crossover designs have been published with individuals with type 1 diabetes as the 
participants free-living on intensive insulin therapy regimens with a short bout of light activity. 
Previous studies involving participants with type 1 diabetes have also used small cohorts of 
participants in their data collection. A review article listed studies on the effect of the timing of 
physical activity and glycemic response, and most studies used a cohort of less than 10 
participants.42 If more studies, such as this one, indicate a beneficial effect of postprandial 
physical activity, a routine could be used to improve glycemic control, prevent or delay the 
progression to diabetic complications. With decreased medical costs, including supplies, insulin 
dosages, and medical visits, not only will money be saved, but quality of life may be improved as 
well. In summary, the research reviewed for this study suggests that postprandial physical 
activity may be one method for attenuating the BG increase resulting from carbohydrate intake 
and therefore, may indirectly reduce the dosage of insulin needed to compensate the 
carbohydrate intake, prevent or delay complications, and reduce costs related to treatment.  
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Research Methodology 
Participants 
Institutional Review Board approval was obtained from University of the Incarnate Word 
prior to the commencement of this study. Volunteers were recruited from former participants of 
type 1 diabetes summer camp in San Antonio, as well as the snowball effect. Participants 
included 7 healthy adult individuals with type 1 diabetes, ages 18 to 30 years old who 
volunteered to participate. To be included in the study, participants had to indicate on a screening 
questionnaire that they: were a non-pregnant healthy adult with type 1 diabetes, over the age of 
18, weighing at least 110 lb, no allergies or intolerances to soy or milk, willing to consume a 
breakfast consisting 8 oz container of Boost® (a nutritional beverage, which provides 240 
Calories and a 41 g load of carbohydrate, which is mainly composed of corn syrup and sugar, 
knew how much insulin to inject for 41 g of carbohydrate), did not have any condition that 
would render them unable to walk at a light pace for 15 minutes, willing to fast for at least 8 
hours, but no longer than 12 hours, prior to data collection; and had documentation of an HbA1c 
reading of <9.5% within the previous month.  Participants meeting the inclusion criteria were 
contacted with instructions, including that they were to refrain from physical activity the 24 
hours prior to data collection, and to contact the investigators if their morning BG was not 
between 70 – 200 mg/dl the day of data collection. If their BG was not in that range, they 
rescheduled for a different day, or corrected with fast acting insulin if high, or a small glass of 
juice or a glucose tablet if low. After the correction, they had to wait at least 1 hour for data 
collection to minimize the impact of the insulin or carbohydrate correction on data collection. 
Two participants had to perform insulin corrections for one of the days, and one needed to 
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perform a carbohydrate correction. All participants signed an informed consent form prior to data 
collection. 
Blood Glucose Measurements 
Glucometers were calibrated with a test solution for mg/dL prior to data collection. All 
participants knew how to determine BG using the glucometer (FreeStyle Lite; Abbott Diabetes 
Care, Inc, Alameda, California) used in this study. The measurement included wiping a finger 
with an alcohol pad and then allowing the finger to dry. A lance was then used to prick the finger 
for a small drop of blood. A glucose test strip was placed at the finger where the small drop of 
blood appeared and then placed in the glucometer for determination of BG level. The finger was 
then wiped again with the alcohol pad. Glucometers were numbered, and the participants used 
the same glucometer for each day of data collection. 
Data Collection 
Data were collected on three Saturdays; participants were required to report for data 
collection on two of the days. On the first day, participants reported to a designated room on the 
University of the Incarnate Word campus after an overnight fast and after determining that their 
morning BG was in the required range. They filled out a form detailing demographic and 
anthropometric information including gender, age, most recent HbA1c value, and number of 
years since diagnosis of diabetes. Weight was measured using a beam balance scale, and height 
was determined using a stadiometer. BMI was calculated as weight in kilograms divided by 
height in squared meters. The participants measured their BG levels using the glucometer twice. 
If the 2 measures were not within 10 mg/dL they measured a third time. The 2 values within 10 
mg/dL were averaged for the baseline glucose value. Each participant then injected the 
appropriate amount of insulin, via insulin pump or a syringe; the amount of insulin administered 
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was based on their carbohydrate to insulin ratio needed for the 41 g Boost beverage and their 
fasting BG levels. Immediately after insulin was self-administered, participants drank a chilled 
Boost® beverage within 10 minutes. The participants then sat quietly and repeated BG 
measurements at 15, 30, 60, 90, and 120 minutes after beverage consumption, and recorded their 
values on a data sheet. The investigators collected the data sheets at the end of the first day of 
data collection. On the second day, the participants followed the same protocol as the first day: 
measured baseline BG, self-administered insulin for 41 g of carbohydrate, and drank a chilled 
Boost® beverage within 10 minutes. However, the second day included the walking intervention. 
The participants engaged in 15 minutes of walking at a light pace (50-60% max HR) 
immediately after consuming the Boost® beverage on the treadmills in the Wellness Center at the 
University of the Incarnate Word. The max HR range for each participant had been calculated for 
them and their HR was self-monitored using a Polar® heart rate monitor. After 15 minutes of 
walking, the participants measured their BG readings at 15, 30, 60, 90, and 120 minutes, as they 
did the first day. After all the data was collected, the data sheets were collected from the 
participants by the investigators. 
         Glucose incremental area under the curve (iAUC) was determined for the walking and 
sedentary days for each participant. The difference from peak to baseline BG was determined. 
Descriptive statistics were performed on the demographic, anthropometric, and BG 
measurements, including iAUC. Paired t-test was used to determine differences in the magnitude 
of BG spike (peak – baseline), iAUC and baseline BG for the walking and sedentary days. SPSS 
was used for data analysis (IBM SPSS Statistics 22, Armork, NY), and significance was set at P 
< .05.  
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Results 
Participant Characteristics 
Seven participants completed the study; 4 males and 3 females, age 22.3 + 4.3 years old, 
with type 1 diabetes diagnosed at age 12.7 + 3.5 years old. Three were Hispanic and 4 were non-
Hispanic Caucasian. BMI ranged from 21.5 to 31.4, with 3 in the healthy range of 18.0-24.9, and 
4 were above the healthy range. The HbA1c was 7.4 + 0.5 %, with a range of 6.6 - 8.1 indicating 
reasonably good control, although only two were in the target range of <7.0. See Table 1 for a 
summary of participant characteristics. 
Blood Glucose Indicators With and Without Walking 
         BG data points were all converted from mg/dL to mmol/L to interpret the results. The 
mean fasting BG for both days were the same with statistical significance (P=.012), but each 
individual fast BG for each day were different for each participant, but there was no significance 
in peak BG between the days (P=.105). However, the magnitude of the BG spike after 
consumption of the breakfast beverage (peak BG – baseline BG) was significantly lower on the 
day the participants walked at a light pace immediately after consumption vs the sedentary day 
(6.4 + 1.2 vs 14.4 + 3.4, respectively, P=.045). The glucose iAUC was lower on the walking day 
compared to the sedentary day as well (241.1 + 155.8 vs 486.6 + 94.5, respectively, P= .016). 
The trends found with the BG spike and iAUC were found in all participants but one. Thus, the 
intervention with light physical activity did attenuate the spike in BG and decreased the iAUC, 
after consumption of a breakfast beverage. The average decrease in the BG spike was 11.8% and 
the average decrease in iAUC was 47.2%. The average percent decrease in the difference 
between peak and baseline from day 1 VS day 2 was 36.2%. The spike in BG and iAUC were 
lower in each participant on the walking day, indicating favorable effect of postprandial walking. 
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See Table 2 for a comparison of BG indicators between the sedentary and walking days, and a 
comparison of the spike in BG between the days for each participant is displayed in Figure 1. 
         Figure 2 shows the iAUC curves for each participant for the sedentary and walking days. 
For most participants, BG peaked at the 30 minute time point on the walking day and 60 minute 
on the sedentary day. Participant 3’s BG dropped to 5.1 mmol/L at the 90 minute time point, so 
she consumed a dextrose tablet and her 120 minute BG value was omitted. Otherwise, the 15 
minutes of walking did not result in hypoglycemia for any of the participants. Figures 3 and 4 
show comparisons of the average Peak-Baseline BG and iAUC, respectively, on sedentary and 
walking days. Figure 5 shows the BG response in each participant, with each BG reading 
represented, on both sedentary and walking days. 
Table 1.  Participant Characteristics 
Variable Mean + SD 
(N = 7) 
Range 
Age (yrs) 22.3 + 4.3 18.0 – 30.0 
Height (cm) 168.0 + 7.3 160.0 – 180.3 
Weight (kg) 71.9 + 10.0 55.5 – 85.6 
BMI1 25.4 + 3.5 21.6 – 31.4 
HbA1c (%) (mmol/mol)2 7.4 + 0.5 6.6 – 8.1 
Years with Type 1 Diabetes 12.7 + 3.5 7.0 – 17.0 
1 BMI = Body Mass Index; weight in kilograms divided by height in meters squared 
2 HbA1c = glycated hemoglobin 
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Table 2. Blood Glucose Indicators of Sedentary and Walking Days 
Variable Day11 
Mean+SD 
(N = 7) 
Day 21 
Mean+SD 
(N = 7) 
P 
Baseline BG 
(mmol/L)2 
8.0 + 2.9 8.0 + 2.5 .012 
Peak BG (mmol/L) 14.4 + 3.4 12.2 + 1.9 .105 
Peak - Baseline3 6.4 + 1.2 4.0 + 2.4 .045 
iAUC (mmol/L/120 
min)4  
468.6 + 94.5 241.1 + 155.8 .016 
1Day 1 was the sedentary day; Day 2 participants walked after consuming the beverage. 
2BG = Blood Glucose 
3The difference between Peak BG and Baseline BG 
4iAUC = Incremental Area Under the Glucose Curve  
  
Figure 1. Difference between baseline and peak blood glucose (mmol/L) for sedentary and 
walking days 
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Figure 2. iAUC (mmol/L/120min) Sedentary VS Walking For Each Participant 
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Figure 3. Comparison of Peak-Baseline BG on Sedentary and Walking Days 
 
 
 
Figure 4. Comparison of iAUC on Sedentary and Walking Days 
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Figure 5. Glucose Curves for Each Participant 
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Discussion 
The results of the present study confirm the beneficial effect of postprandial walking, at a 
light pace, on the glycemic response to a meal. In contrast to other studies, the participants in the 
present study followed their usual insulin regimen, administered a bolus of insulin appropriate 
for the 41 g carbohydrate load provided by the Boost® beverage, and the physical activity was 
shorter in duration, commencing immediately after meal consumption.11-15,32,39 Other studies did 
control for fasting BG levels by the use of an artificial pancreas or insulin infusions the night 
before data collection and the present study did not.11-14,39 Although the fasting BG levels 
differed in some of the participants on the two data collection days, all but one of the seven  
participants had a lower spike in BG (peak - baseline BG) and lower iAUC on the postprandial 
walking day compared to the sedentary day. The results showed that the spike (peak - baseline) 
in BG was diminished by an average of 36.2% with the postprandial physical activity 
intervention. The iAUC was also decreased by an average of 47.2% with postprandial walking. 
One participant had a 90 minute BG in the 80 mg/dL range, so a dextrose tablet was taken to 
prevent hypoglycemia, and the 120 minute BG was not used in the data analysis.  A decrease in 
the spike in BG and glycemic response from a carbohydrate intake would be beneficial for 
individuals with type 1 diabetes because it could possibly decrease the risk for long term 
complications and improved health status.  
The shorter duration of postprandial physical activity in the present study, 15 min of 
walking immediately after meal consumption at a light pace, may be a more realistic approach 
for compliance than the studies that used longer durations and intensities of physical activity or a 
wait period after the meal before commencing with physical activity.11-14,32,39 For example, on a 
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lunch hour, 15 minutes of walking is realistic, whereas 30-45 minutes of physical activity would 
not be feasible in a lunch hour.  
         One concern related to physical activity in individuals with type 1 diabetes is 
hypoglycemia, which is why light walking was chosen as the postprandial physical 
activity.31,34,35 Since exercising muscle and insulin have a synergistic effect on facilitating BG 
uptake by muscle cells, those administering insulin with meals and performing physical activity 
right after food consumption could be at increased risk for hypoglycemia. With cautious BG 
monitoring or the use of a continuous glucose monitor and being mindful of the time of day and 
food consumption, individuals with type 1 diabetes can successfully partake in physical activity, 
avoiding hypo- or hyperglycemia.16,42 In addition to glycemic control, another benefit of physical 
activity overall, in individuals with type 1 diabetes, is to potentially decrease the risk of 
secondary complications, such as CVD, stroke, obesity, micro-, and macrovascular disease by 
means of the glycemic control.24  
         In interpreting the results of the present study, some limitations must be considered. The 
study included a low participant number, although there was enough power to achieve statistical 
significance. In addition, fasting BG was variable among many participants on the two testing 
days. Morning insulin injection or a small carbohydrate dose was needed to correct BG levels to 
meet the range for participation by a few participants, who were required to wait an hour after 
correction before data collection commencement to minimize confounding effects. The age 
group of participants, all young adults, ages 18 to 30 years old, limits the generalizability of the 
results, as older or younger individuals may not respond the same. Another limitation of the 
study would be the method used to measure BG values, which was via glucometers, which are 
not as reliable and valid as venous blood samples. The study design component of having the 
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participants monitor and record their blood glucose readings, and monitor their heart rates is 
another limitation that brings potential error in the data because the data readings could be easily 
changed to favor the hypothesis. The participants also determined the amount of insulin 
themselves and self-administered the insulin without recording the amount of insulin injected for 
the 41 g of carbohydrates.  
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Conclusion 
          Prevention of BG spikes is important for individuals with type 1 diabetes, not only to 
help with achieving glycemic control, but to also decrease the amount of insulin needed to 
achieve control and to prevent secondary complications from forming that could potentially 
impair quality of life, such as CVD, stroke, and microvascular disease. The results of the present 
study show that a short bout (15 minutes) of light postprandial physical activity, consisting of 
walking, can blunt the BG spike postprandial to a Boost® beverage in participants with type 1 
diabetes on intensive insulin therapy regimens. With mounting evidence, health professionals 
may consider recommending postprandial physical activity to their patients to optimize glycemic 
control, with the caution that BG must be closely monitored. A continuous BG monitor would be 
ideal to monitor BG when exercising.  Although there appears to be a beneficial effect of 
postprandial physical activity on glycemic response to a meal, the long-term effect of regular 
postprandial activity on glycemic control and development of complications is unknown. Future 
studies need to examine the effect of light postprandial activity for some or all meals, following 
participants over a period of time to determine if HbA1c levels are influenced.   
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Appendix A 
  
GLOSSARY OF ABBREVIATIONS, TERMS, AND VARIABLES 
  
AGEs: Advance glycation end products: the 
result of the post-translational modification 
of proteins, lipids, or DNA, which results in 
the crosslinking of collagen and stiffening of 
connective tissue, including the tissue found 
in the arteries, attracting macrophages, 
monocytes, cardiac fibroblasts, and vascular 
smooth muscle cells.10 
Atherosclerosis: a disease in which plaque 
builds up in the arteries caused by 
atherogenesis that is a chronic and local 
inflammatory response to lipid profiles.1 
AUC: Area under the glucose curve 
Beta cell autoimmune: antibodies have 
been made against the host’s own beta cells 
found in the pancreas and the body’s 
immune system attacks itself.1 
BG: Blood Glucose 
BMI: Body Mass Index; measurement used 
to determine weight status and is calculated 
as weight in kilograms divided by height in 
squared meters.1 
Carbohydrate Exchange: a group of foods 
that are divided into carbohydrates, which 
include starches, fruits, milk, sweets, 
desserts, and other carbohydrates, including 
non-starchy vegetables, meat and meat 
substitutes, fats, and free foods.1 
Catecholamines: organic molecule released 
by the adrenal medulla that include 
epinephrine and norepinephrine that can act 
as a hormone or neurotransmitter.1 
CDE: Certified Diabetes Educator 
Conventional Regimen: involves 2-3 
insulin injections a day with a mixture of 
insulin types that peaked at specific times 
when meal with controlled carbohydrate 
content had to be consumed.1 
Coronary Bypass: is a procedure that 
diverts the flow of blood around a section of 
a blocked artery in your heart to restore 
regular blood flow.58 
C Reactive Protein: a positive acute phase 
protein that is increased during 
inflammation and contributes to an 
inflammatory response.1 
CVD: Cardiovascular Disease: a group of 
interrelated diseases including coronary 
heart disease, atherosclerosis, hypertension, 
ischemic heart disease, peripheral vascular 
disease, and heart failure.1 
DCCT: Diabetes Control and Complications 
Trial: one of the classic clinical trials that 
has linked glycemic control and the 
development of complications in individuals 
with type 1 and type 2 diabetes, with also 
signifying the importance to nutrition 
therapy to achieve glycemic control. 1400 
participants were administered insulin either 
as an intensive regimen, with multiple 
injections or the use of an insulin pump, or a 
conventional regimen of one or two 
injections per day. The results were that if 
the conventional regimen participants could 
reach the same glycemic control as the 
intensive, then the risk of complications 
could be reduced by 50-75%.1 
DKA: Diabetic Ketoacidosis: a 
complication from diabetes, characterized 
by the disruption of carbohydrate, protein, 
and fat metabolism, in which produces 
ketones in response to glucose not being 
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available for metabolism, that can be 
potentially life threatening, but reversible.1 
Dyspnea: shortness of breath.1 
GI: Glycemic Index: a measurement of the 
relative area under the postprandial glucose 
curve of 50 g of carbohydrates, from one 
food item, compared to 50 g of a standard 
food of measurement, such as white bread.1 
GL: Glycemic Load; GI multiplied by the 
amount of carbohydrate per serving that 
measures the impact of a certain amount of 
food on glycemic response.18 
Glucagon: a hormone that is counter-
reactive to insulin and restores blood 
glucose to normal levels by promoting 
glycogenolysis and gluconeogenesis.1 
Glucocorticoids: are steroid hormones 
(cortisol) with anti-inflammatory properties 
produced by the human body.59 
Glucometer: calibrated, hand held device 
that is used to self monitor blood glucose.1 
GLUT 4: glucose transporter that is insulin 
dependent found in the adipose and muscle 
cells.1 
Grams (g): measurement of mass 
HbA1c: Glycated Hemoglobin: a test value 
that reflects long-term glucose 
concentrations by showing the amount of 
proteins that are exposed to glucose and the 
weighted average of plasma glucose 
concentration over several weeks time 
period.1 
Hypoglycemia: a state when the blood 
glucose concentration falls below the normal 
range.1 
Hyperglycemia: a state when the blood 
glucose concentration elevates above the 
normal range.1 
Hypertension: persistently high arterial 
blood pressure based on the force exerted 
per unit area of the artery wall. Diagnosed as 
a systolic blood pressure of 120 mmHg or 
higher and a diastolic of 80 mmHg or 
higher.1 
iGAUC: Incremental glucose area under the 
curve 
Insulin Bolus: administration of insulin 
used in response to a meal intake and or to 
correct for hyperglycemia.1 
Insulin: a hormone that is produced by the β 
cells, which are in the pancreas, in response 
to food ingested to maintain blood glucose 
homeostasis.1 
Insulin Pump: an option of insulin therapy 
used in individuals with type 1 diabetes that 
provides a basal of rapid acting or short 
acting insulin continuously and a bolus for 
when carbohydrates are consumed.1 
Intensive Regimen: involves administering 
a bolus of fast acting insulin, at each meal, 
in accordance with the carbohydrate content 
of the meal.1  
Ischemic Heart Disease: occurs when 
blood flow is restricted or reduced to the 
heart due to narrowing of arteries.1 
JDRF: Juvenile Diabetes Research 
Foundation 
Ketones: produced from acetyl CoA when 
there is inadequate glucose in the cell to 
facilitate carbohydrate metabolism and 
energy production, to be used by the brain, 
heart, and muscle.1 
LDL: Low Density Lipoprotein: a small cell 
that is made up of a lipoprotein outside that 
surrounds a large amount of cholesterol 
inside, which is also labeled as the “bad” 
cholesterol.1  
Long acting insulin: a type of insulin used 
in a conventional regimen, with an onset of 
action being 2-4 hours, with no peak action 
 51 
period, and a usual effective duration being 
18-24 hrs depending on the mixture (Lantus 
or Levemir); BG should be monitored at 10-
12 hrs.1 
Microalbuminuria: low, but abnormal 
albumin levels present in the urine (30-299 
mg/24 hours) that is considered the earliest 
sign of clinical evidence for nephropathy.1 
Nephropathy: a microvascular disease that 
involves damage to the small blood vessels 
in the kidney allowing proteins to enter the 
urine and present with microalbuminuria 
caused by excess BG.1 
Neuropathy: a microvascular disease that 
involves peripheral nerve damage to feet and 
hands as well as autonomic nerve damage 
caused by excess BG in the small blood 
vessels.1 
OGTT: Oral Glucose Tolerance Test: A 
procedure used to diagnose diabetes that 
requires the patient to fast prior to testing 
and then ingesting a glucose solution at 
testing, followed by a blood glucose reading 
hours later. The protocol varies based on 
which version is used.1 
Oxidative Stress: stress in the body caused 
by an increase in oxidant generation, a 
decrease in antioxidant production, or a 
failure to repair oxidative damage.1 
Rapid acting insulin: a type of insulin used 
in both intensive and conventional regimens 
that has an onset of action of less than 15 
min, peak action at around 1-2 hrs, and an 
effective duration of 3-4 hrs; BG should be 
monitored at 2 hrs.1 
Retinopathy: a microvascular disease that 
involves the loss of retinal vasculature and 
ischemia with increased occurrence of 
hemorrhages, leading to increased ocular 
pressure and glaucoma formation, caused by 
excess BG in the small blood vessels.1 
ROS: Reactive Oxygen Species: free 
radicals, reactive anions containing oxygen 
atoms, or molecules containing oxygen 
atoms that can either produce free radicals 
or are chemically activated by them, which 
all cause cell damage as a result of oxidative 
stress.1 
Type 1 Diabetes: a disease characterized by 
high blood glucose concentrations in the 
body resulting from pancreatic β-cell 
destruction by an autoimmune response or 
idiopathic.1 
Type 2 Diabetes: a disease characterized by 
gradual elevation of blood glucose 
concentrations in the body resulting from 
genetic disposition and environmental 
factors such as family history, obesity, race, 
ethnicity, and physical inactivity.1 
VO2 Max: the measure of the maximum 
volume of oxygen that an individual can use 
during exercise.60 
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